Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
11.92
+0.09 (0.76%)
Feb 4, 2026, 10:25 AM CST
SHE:002728 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 215.4 | 457.41 | 647.25 | 739.66 | 372.47 | 325.12 |
Trading Asset Securities | 100 | - | - | - | - | 250 |
Cash & Short-Term Investments | 315.4 | 457.41 | 647.25 | 739.66 | 372.47 | 575.12 |
Cash Growth | -47.42% | -29.33% | -12.49% | 98.58% | -35.24% | 0.27% |
Accounts Receivable | 155.47 | 205.32 | 156 | 133.02 | 126.66 | 142.17 |
Other Receivables | 0.89 | 9.38 | 13.94 | 16.87 | 1.36 | 3.44 |
Receivables | 156.36 | 214.7 | 169.94 | 149.9 | 128.02 | 145.62 |
Inventory | 259.6 | 264.38 | 271.83 | 208.23 | 195.31 | 193.04 |
Prepaid Expenses | - | - | - | - | 0.69 | 0.31 |
Other Current Assets | 32.51 | 14.46 | 16.13 | 31.08 | 15.45 | 15.12 |
Total Current Assets | 763.88 | 950.95 | 1,105 | 1,129 | 711.95 | 929.21 |
Property, Plant & Equipment | 729.58 | 721.4 | 656.49 | 648.01 | 601.68 | 554.23 |
Long-Term Investments | 13.5 | 13.5 | 13.5 | 13.5 | - | - |
Goodwill | 517.6 | 517.6 | 529.23 | 542.4 | 542.4 | 565.45 |
Other Intangible Assets | 135.8 | 138.63 | 151.24 | 153.87 | 156.75 | 139.89 |
Long-Term Deferred Tax Assets | 20.78 | 21.85 | 18.4 | 18.81 | 17.18 | 18.27 |
Long-Term Deferred Charges | 16.96 | 17.41 | 13.45 | 11.48 | 15.6 | 34.73 |
Other Long-Term Assets | 22.51 | 19.54 | 25.18 | 28.67 | 20.65 | 14.34 |
Total Assets | 2,221 | 2,401 | 2,513 | 2,546 | 2,066 | 2,256 |
Accounts Payable | 67.64 | 44.83 | 83 | 76.29 | 52.35 | 57.24 |
Accrued Expenses | 7.47 | 19.37 | 32.5 | 30.42 | 20.09 | 14.35 |
Short-Term Debt | 260 | 516.09 | 306 | 633.68 | 377 | 770.12 |
Current Portion of Long-Term Debt | - | - | - | 213.5 | - | - |
Current Income Taxes Payable | 15.45 | 0.72 | 13.65 | 4.86 | 8.59 | 4.48 |
Current Unearned Revenue | 23.57 | 11.05 | 24.26 | 130.69 | 31.06 | 26.12 |
Other Current Liabilities | 6.29 | 3.96 | 6.36 | 19.81 | 7.25 | 5.92 |
Total Current Liabilities | 380.43 | 596.02 | 465.77 | 1,109 | 496.34 | 878.22 |
Long-Term Debt | - | - | - | - | 285.18 | 272.12 |
Long-Term Unearned Revenue | 18.08 | 20.57 | 20.77 | 18.51 | 11.72 | 11.68 |
Long-Term Deferred Tax Liabilities | 19.15 | 19.36 | 15.42 | 14.71 | 11.27 | 13.66 |
Total Liabilities | 417.67 | 635.94 | 501.95 | 1,142 | 804.51 | 1,176 |
Common Stock | 513 | 512.21 | 364.69 | 229.18 | 221.64 | 203.52 |
Additional Paid-In Capital | 848.26 | 844.13 | 982 | 575.92 | 460.91 | 292.5 |
Retained Earnings | 536.07 | 495.8 | 657.68 | 553.51 | 519.38 | 524.79 |
Treasury Stock | -101.19 | -93.86 | - | - | - | - |
Comprehensive Income & Other | 6.79 | 6.65 | 6.31 | 44.53 | 59.75 | 59.63 |
Shareholders' Equity | 1,803 | 1,765 | 2,011 | 1,403 | 1,262 | 1,080 |
Total Liabilities & Equity | 2,221 | 2,401 | 2,513 | 2,546 | 2,066 | 2,256 |
Total Debt | 260 | 516.09 | 306 | 847.18 | 662.18 | 1,042 |
Net Cash (Debt) | 55.4 | -58.68 | 341.25 | -107.52 | -289.71 | -467.12 |
Net Cash Per Share | 0.13 | -0.11 | 0.74 | -0.25 | -0.72 | -1.20 |
Filing Date Shares Outstanding | 499.27 | 500.58 | 510.56 | 449.27 | 434.42 | 398.89 |
Total Common Shares Outstanding | 499.27 | 499.49 | 510.56 | 449.19 | 434.42 | 398.89 |
Working Capital | 383.44 | 354.93 | 639.39 | 19.62 | 215.61 | 51 |
Book Value Per Share | 3.61 | 3.53 | 3.94 | 3.12 | 2.90 | 2.71 |
Tangible Book Value | 1,150 | 1,109 | 1,330 | 706.87 | 562.55 | 375.09 |
Tangible Book Value Per Share | 2.30 | 2.22 | 2.61 | 1.57 | 1.29 | 0.94 |
Buildings | - | 527.78 | 542.22 | 412.29 | 419.33 | 428.15 |
Machinery | - | 418.7 | 329.97 | 259.01 | 254.01 | 252.67 |
Construction In Progress | - | 157.88 | 131.95 | 280.88 | 198.46 | 118.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.